Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings
© Niyomnaitham et al.; licensee BioMed Central Ltd. 2014
Received: 12 November 2013
Accepted: 27 March 2014
Published: 4 April 2014
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|12 Nov 2013||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|28 Jan 2014||Reviewed||Reviewer Report - Atonu Rabbani|
|16 Feb 2014||Reviewed||Reviewer Report - anthony smith|
|3 Mar 2014||Author responded||Author comments - SUVIMOL NIYOMNAITHAM|
|Resubmission - Version 3|
|3 Mar 2014||Submitted||Manuscript version 3|
|19 Mar 2014||Author responded||Author comments - SUVIMOL NIYOMNAITHAM|
|Resubmission - Version 4|
|19 Mar 2014||Submitted||Manuscript version 4|
|27 Mar 2014||Editorially accepted|
|4 Apr 2014||Article published||10.1186/1472-6963-14-151|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.